NCT03118232

Brief Summary

This is a cluster-randomized trial of nursing homes to assess whether decolonization with routine chlorhexidine bathing and periodic use of nasal antiseptics can reduce hospitalizations associated with infections, antibiotic utilization, and multi-drug resistant organism (MDRO) prevalence. The comparator arm will be routine bathing care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13,952

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Apr 2017

Longer than P75 for phase_4

Geographic Reach
1 country

28 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

April 3, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 18, 2017

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2023

Completed
3 months until next milestone

Results Posted

Study results publicly available

December 27, 2023

Completed
Last Updated

December 27, 2023

Status Verified

December 1, 2023

Enrollment Period

6.5 years

First QC Date

February 21, 2017

Results QC Date

November 9, 2023

Last Update Submit

December 5, 2023

Conditions

Keywords

Nursing HomesHealth FacilitiesInfectionsReadmissionsMulti-Drug resistanceAntibiotic Use

Outcome Measures

Primary Outcomes (1)

  • Hospital Transfers Due to Infection

    Probability that a transfer to a hospital is due to an infection

    18 months

Secondary Outcomes (1)

  • All Hospital Transfers

    18 months

Other Outcomes (4)

  • Multidrug-resistant Organism (MDRO) Colonization (Secondary Manuscript)

    Once in baseline and once at end-intervention (month 15-18 of intervention period)

  • Hospital Transfers Due to Infection in Long Stay and Short Stay Subsets (Secondary Manuscript, Added by Steering Committee Decision on 3/22/2017)

    18 months

  • All Hospital Transfers in Long Stay and Short Stay Subsets (Secondary Manuscript, Added by Steering Committee Decision on 3/22/2017)

    18 months

  • +1 more other outcomes

Study Arms (2)

Decolonization

ACTIVE COMPARATOR

Nursing homes assigned to this arm will perform decolonization using topical antiseptic products.

Drug: Chlorhexidine gluconate (CHG)Drug: Iodophor (10% povidone-iodine)

Routine Bathing

NO INTERVENTION

Routine bathing per facility protocol.

Interventions

2% no-rinse chlorhexidine gluconate (CHG) for bed bathing and 4% rinse-off CHG showering. Bathing frequency will be per routine plus admission bathing.

Decolonization

Nasal decolonization using topical 10% povidone-iodine nasal swabs will be applied to all residents on admission for 5 days twice daily plus every other week Monday-Friday using a twice daily regimen.

Decolonization

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Nursing homes will be eligible to participate if they meet the following criteria:
  • Licensed nursing home in Orange County or Southern Los Angeles County serving adults
  • Minimal use of chlorhexidine bathing\*
  • Minimal use of nasal decolonization\* \*Minimal use defined as \<15% of residents receiving at least one chlorhexidine bath or nasal decolonization treatment during their nursing home stay.

You may not qualify if:

  • Nursing homes will not be eligible to participate if they meet the following criteria:
  • Facilities routinely using decolonization
  • Dedicated psychiatric nursing homes
  • Facilities with a resident population with \>=20% combative patients
  • Pediatric facilities
  • Note: in any participating nursing home, residents with active end-of-life comfort care only measures are excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (28)

Buena Vista Care Center

Anaheim, California, 92802, United States

Location

Walnut Village Rehabilitation and Care Center

Anaheim, California, 92802, United States

Location

Anaheim Crest Nursing Center

Anaheim, California, 92804, United States

Location

Sun Mar Nursing Center

Anaheim, California, 92804, United States

Location

West Anaheim Extended Care

Anaheim, California, 92804, United States

Location

Bel Tooren Villa Convalescent Hospital

Bellflower, California, 90706, United States

Location

Capistrano Beach Care Center

Capistrano Beach, California, 92624, United States

Location

Downey Care Center

Downey, California, 90242, United States

Location

Gordon Lane Care Center

Fullerton, California, 92831, United States

Location

Windsor Gardens Care Center of Fullerton

Fullerton, California, 92832, United States

Location

Terrace View Care Center

Fullerton, California, 92835, United States

Location

Pacific Haven Subacute Healthcare Center

Garden Grove, California, 92843, United States

Location

Las Flores Convalescent Hospital

Gardena, California, 90249, United States

Location

Park Regency Care Center

La Habra, California, 90631, United States

Location

Regency Oaks Post Acute Care Center

Long Beach, California, 90804, United States

Location

Windsor Convalescent of North Long Beach

Long Beach, California, 90805, United States

Location

Bixby Knolls Healthcare Center

Long Beach, California, 90807, United States

Location

Pacific Villa Inc.

Long Beach, California, 90807, United States

Location

Vista Cove Care Center at Long Beach

Long Beach, California, 90807, United States

Location

Intercommunity Care Center

Long Beach, California, 90815, United States

Location

Royal Oaks Care Center

Lynwood, California, 90262, United States

Location

Norwalk Skilled Nursing and Wellness Center

Norwalk, California, 90650, United States

Location

Villa Elena Care Center

Norwalk, California, 90650, United States

Location

Harbor Post-Acute Care Center

Torrance, California, 90502, United States

Location

Heritage Rehabilitation Center

Torrance, California, 90502, United States

Location

Sunnyside Nursing Center

Torrance, California, 90502, United States

Location

Torrance Care Center West

Torrance, California, 90503, United States

Location

Del Amo Gardens Care Center

Torrance, California, 90505, United States

Location

Related Publications (1)

  • Miller LG, McKinnell JA, Singh RD, Gussin GM, Kleinman K, Saavedra R, Mendez J, Catuna TD, Felix J, Chang J, Heim L, Franco R, Tjoa T, Stone ND, Steinberg K, Beecham N, Montgomery J, Walters D, Park S, Tam S, Gohil SK, Robinson PA, Estevez M, Lewis B, Shimabukuro JA, Tchakalian G, Miner A, Torres C, Evans KD, Bittencourt CE, He J, Lee E, Nedelcu C, Lu J, Agrawal S, Sturdevant SG, Peterson E, Huang SS. Decolonization in Nursing Homes to Prevent Infection and Hospitalization. N Engl J Med. 2023 Nov 9;389(19):1766-1777. doi: 10.1056/NEJMoa2215254. Epub 2023 Oct 10.

MeSH Terms

Conditions

Infections

Interventions

chlorhexidine gluconateIodophorsPovidone-Iodine

Intervention Hierarchy (Ancestors)

Iodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Results Point of Contact

Title
Dr. Susan Huang
Organization
University of California, Irvine

Study Officials

  • Susan Huang, MD MPH

    University of California, Irvine

    PRINCIPAL INVESTIGATOR
  • Loren Miller, MD MPH

    Harbor UCLA

    STUDY DIRECTOR
  • James McKinnell, MD

    Harbor UCLA

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Medical Director of Epidemiology and Infection Prevention

Study Record Dates

First Submitted

February 21, 2017

First Posted

April 18, 2017

Study Start

April 3, 2017

Primary Completion

October 10, 2023

Study Completion

October 10, 2023

Last Updated

December 27, 2023

Results First Posted

December 27, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

The resource sharing plan involves sharing 1) sharing of trial materials and tools, and 2) making bacterial isolates available.

Locations